當(dāng)前位置:首頁 > 產(chǎn)品中心 > 細(xì)胞系 > 人源細(xì)胞系
產(chǎn)品分類
Product Category相關(guān)文章
Related ArticlesNCCIT was established by Shinichi Teshima (National Cancer Institute, Tokyo, Japan) in 1985 from a mediastinal mixed germ cell tumor.
HTh-7 (人甲狀腺癌細(xì)胞) (STR鑒定正確)
CX-1(人結(jié)腸癌細(xì)胞)(STR鑒定正確)
The D341 Med cell line was established in 1988 by Friedman et al. from tumor tissue taken from a boy with medulloblastoma.
Established from the peripheral blood of a 6-month-old girl with acute megakaryoblastic leukemia (AML M7) at diagnosis in 1987; subline of the growth factor-independent cell line M-07.
HBL-100細(xì)胞是由E·V·Gaffney及其同事從一位沒有乳癌家族史的供者乳汁中建立的一株上皮細(xì)胞;培養(yǎng)出來的HBL-100細(xì)胞染色體組型在第7代時(shí)就不正常。電鏡照片顯示,HBL-100細(xì)胞內(nèi)有微絲、張力原纖維和橋粒。Southern轉(zhuǎn)移表明,HBL-100細(xì)胞有整合型SV40病毒基因,不可以當(dāng)作正常細(xì)胞。